Drugs Generic Stock: Zoetis Inc (NYSE:ZTS), Mylan Inc (NASDAQ:MYL), Actavis plc (NYSE:ACT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Zoetis Inc. (NYSE:ZTS) will begin trading ex-dividend on January 28, 2014. A cash dividend payment of $0.072 per share is scheduled to be paid on March 04, 2014. Shareholders who purchased ZTS stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 10.77% increase over the prior quarter. Zoetis Inc (NYSE:ZTS) stock opened at $30.39 in last session, and closed at $30.36, while the day range of ZTS stock is $30.07 – $30.54. The stock showed a negative weekly performance of -3.28%.

Mylan Inc. (Nasdaq:MYL), one of the world’s leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world’s first trastuzumab biosimilar in India. Mylan Inc (NASDAQ:MYL) stock opened at $44.85, in last session and closed at $45.41, by losing -0.31%. The 52 week range of MYL is $27.66 – $46.73. Company’s market capitalization is $17.38billion.

Actavis plc (NYSE:ACT) has announced a realignment of its global strategic business structure to maximize the company’s newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis’ position for continued long-term growth. Actavis plc (NYSE:ACT) stock advanced 1.23% and finished the last session at $188.98. The EPS of the stock remained -4.36. Company’s market capitalization is $25.04billion.

Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for approval of AVP-825, its innovative Breath Powered investigational drug-device combination product for the acute treatment of migraine. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened the session at $3.87, and closed the session at $3.75. The 52 week range of the AVNR stock remained $2.60 – $6.00 and the day range was $3.73 – $3.96.